Clinical trial NCT04847778 - References

Diabetes Mellitus, Type 1 — Assess the Impact of Insulclock on Glycemic Variability and Treatment Compliance in Uncontrolled DM1 Patients

Citation(s)

•   American Diabetes Association
  7. Approaches to Glycemic Treatment. Diabetes Care. 2016 Jan;39 Suppl 1:S52-9. doi: 10.2337/dc16-S010. Review.
•   Årsand E, Muzny M, Bradway M, Muzik J, Hartvigsen G
  Performance of the first combined smartwatch and smartphone diabetes diary application study. J Diabetes Sci Technol. 2015 May;9(3):556-63. doi: 10.1177/1932296814567708. Epub 2015 Jan 14.
•   Borschuk AP, Everhart RS
  Health disparities among youth with type 1 diabetes: A systematic review of the current literature. Fam Syst Health. 2015 Sep;33(3):297-313. doi: 10.1037/fsh0000134. Epub 2015 May 18. Review.
•   Burdick J, Chase HP, Slover RH, Knievel K, Scrimgeour L, Maniatis AK, Klingensmith GJ
  Missed insulin meal boluses and elevated hemoglobin A1c levels in children receiving insulin pump therapy. Pediatrics. 2004 Mar;113(3 Pt 1):e221-4.
•   Celik S, Cosansu G, Erdogan S, Kahraman A, Isik S, Bayrak G, Bektas B, Olgun N
  Using mobile phone text messages to improve insulin injection technique and glycaemic control in patients with diabetes mellitus: a multi-centre study in Turkey. J Clin Nurs. 2015 Jun;24(11-12):1525-33. doi: 10.1111/jocn.12731. Epub 2014 Nov 25.
•   Danne T, Forst T, Deinhard J, Rose L, Moennig E, Haupt A
  No effect of insulin pen with memory function on glycemic control in a patient cohort with poorly controlled type 1 diabetes: a randomized open-label study. J Diabetes Sci Technol. 2012 Nov 1;6(6):1392-7.
•   Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, Rand L, Siebert C
  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993 Sep 30;329(14):977-86.
•   Gomez-Peralta F, Abreu C, Gomez-Rodriguez S, Cruz-Bravo M, María-Sanchez C, Poza G, Ruiz-Valdepeñas L
  Efficacy of Insulclock in Patients with Poorly Controlled Type 1 Diabetes Mellitus: A Pilot, Randomized Clinical Trial. Diabetes Technol Ther. 2020 Sep;22(9):686-690. doi: 10.1089/dia.2019.0427. Epub 2020 Mar 5.
•   Gomez-Peralta F, Abreu C, Gomez-Rodriguez S, Ruiz L
  Insulclock: A Novel Insulin Delivery Optimization and Tracking System. Diabetes Technol Ther. 2019 Apr;21(4):209-214. doi: 10.1089/dia.2018.0361. Epub 2019 Mar 21.
•   Guo X, Sommavilla B, Vanterpool G, Qvist M, Bethien M, Lilleøre SK
  Evaluation of a new durable insulin pen with memory function among people with diabetes and healthcare professionals. Expert Opin Drug Deliv. 2012 Apr;9(4):355-6. doi: 10.1517/17425247.2012.671808.
•   Klausmann G, Hramiak I, Qvist M, Mikkelsen KH, Guo X
  Evaluation of preference for a novel durable insulin pen with memory function among patients with diabetes and health care professionals. Patient Prefer Adherence. 2013 Apr 5;7:285-92. doi: 10.2147/PPA.S41929. Print 2013.
•   Luo M, Tan KHX, Tan CS, Lim WY, Tai ES, Venkataraman K
  Longitudinal trends in HbA(1c) patterns and association with outcomes: A systematic review. Diabetes Metab Res Rev. 2018 Sep;34(6):e3015. doi: 10.1002/dmrr.3015. Epub 2018 May 22.
•   Martyn-Nemeth P, Schwarz Farabi S, Mihailescu D, Nemeth J, Quinn L
  Fear of hypoglycemia in adults with type 1 diabetes: impact of therapeutic advances and strategies for prevention - a review. J Diabetes Complications. 2016 Jan-Feb;30(1):167-77. doi: 10.1016/j.jdiacomp.2015.09.003. Epub 2015 Sep 7. Review.
•   Peyrot M, Rubin RR, Kruger DF, Travis LB
  Correlates of insulin injection omission. Diabetes Care. 2010 Feb;33(2):240-5. doi: 10.2337/dc09-1348.
•   Phan TL, Hossain J, Lawless S, Werk LN
  Quarterly visits with glycated hemoglobin monitoring: the sweet spot for glycemic control in youth with type 1 diabetes. Diabetes Care. 2014 Feb;37(2):341-5. doi: 10.2337/dc13-0980. Epub 2013 Sep 23.
•   Ruiz-Ramos M, Escolar-Pujolar A, Mayoral-Sánchez E, Corral-San Laureano F, Fernández-Fernández I
  [Diabetes mellitus in Spain: death rates, prevalence, impact, costs and inequalities]. Gac Sanit. 2006 Mar;20 Suppl 1:15-24. Review. Spanish.
•   Soriguer F, Goday A, Bosch-Comas A, Bordiú E, Calle-Pascual A, Carmena R, Casamitjana R, Castaño L, Castell C, Catalá M, Delgado E, Franch J, Gaztambide S, Girbés J, Gomis R, Gutiérrez G, López-Alba A, Martínez-Larrad MT, Menéndez E, Mora-Peces I, Ortega E, Pascual-Manich G, Rojo-Martínez G, Serrano-Rios M, Valdés S, Vázquez JA, Vendrell J
  Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia. 2012 Jan;55(1):88-93. doi: 10.1007/s00125-011-2336-9. Epub 2011 Oct 11.
•   Stolpe S, Kroes MA, Webb N, Wisniewski T
  A Systematic Review of Insulin Adherence Measures in Patients with Diabetes. J Manag Care Spec Pharm. 2016 Nov;22(11):1224-1246. Review.

Randomized Clinical Trial to Assess the Efficacy of the System Insulclock® 360 for Insulin Treatment Management in Type 1 Diabetes Patients With Insufficient Glycemic Control

Details for clinical trial NCT04847778